esketamine has been researched along with Depression, Endogenous in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 8 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguiar, PM; Lima, TM; Visacri, MB | 1 |
| Endo, K; Kodama, W; Terao, I; Tsuge, T | 1 |
| Bell, E; Hamilton, A; Malhi, GS; Morris, G | 1 |
| Liu, P; Peng, S; Wang, J; Wang, Y; Xu, F; Xu, X | 1 |
| Aksay, SS; Beuschlein, J; Bumb, JM; Janke, C; Karl, S; Kranaster, L; Pfeifer, AM; Remennik, D; Sartorius, A | 1 |
| Bauer, M; Cleare, A; Findeis, H; Ritter, P; Sauer, C | 1 |
| Preskorn, SH | 1 |
| Jesus-Nunes, AP; Lins-Silva, DH; Quarantini, LC; Souza-Marques, B; Vieira, F | 1 |
4 review(s) available for esketamine and Depression, Endogenous
| Article | Year |
|---|---|
Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses.
Topics: Antidepressive Agents; Depressive Disorder; Humans; Ketamine; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Suicidal Ideation; Systematic Reviews as Topic | 2022 |
Comparative efficacy, tolerability and acceptability of intravenous racemic ketamine with intranasal esketamine, aripiprazole and lithium as augmentative treatments for treatment-resistant unipolar depression: A systematic review and network meta-analysis
Topics: Adult; Antidepressive Agents; Aripiprazole; Depression; Depressive Disorder; Depressive Disorder, Treatment-Resistant; Humans; Ketamine; Lithium; Network Meta-Analysis | 2024 |
A New Paradigm for Achieving a Rapid Antidepressant Response.
Topics: Antidepressive Agents; Depressive Disorder; Humans; Ketamine; Quinolones; Thiophenes | 2020 |
Consistency of the Antidepressant Effect of Intranasal Esketamine in Phase 3 Clinical Trials.
Topics: Administration, Intranasal; Antidepressive Agents; Clinical Trials, Phase III as Topic; Depressive Disorder; Drug Approval; Humans; Ketamine; United States; United States Food and Drug Administration | 2021 |
1 trial(s) available for esketamine and Depression, Endogenous
| Article | Year |
|---|---|
Use of Various Doses of S-Ketamine in Treatment of Depression and Pain in Cervical Carcinoma Patients with Mild/Moderate Depression After Laparoscopic Total Hysterectomy.
Topics: Adult; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Carcinoma; Depression; Depressive Disorder; Double-Blind Method; Female; Humans; Hysterectomy; Ketamine; Middle Aged; Pain Measurement; Pain, Postoperative; Serotonin; Uterine Cervical Neoplasms | 2020 |
3 other study(ies) available for esketamine and Depression, Endogenous
| Article | Year |
|---|---|
Empirical ratio of the combined use of S-ketamine and propofol in electroconvulsive therapy and its impact on seizure quality.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthesia; Anesthetics, Intravenous; Depressive Disorder; Drug Combinations; Electroconvulsive Therapy; Female; Humans; Ketamine; Male; Middle Aged; Process Assessment, Health Care; Propofol; Retrospective Studies; Seizures; Young Adult | 2021 |
Urothelial toxicity of esketamine in the treatment of depression.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Injections, Subcutaneous; Ketamine; Male; Middle Aged; Urothelium | 2020 |
Letter to the editor about "comparative effectiveness of esketamine in the treatment of anhedonia in bipolar and unipolar depression".
Topics: Anhedonia; Bipolar Disorder; Depressive Disorder; Humans; Ketamine | 2021 |